Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas. - Wikidata - awgldk - TriplyDB

Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.

Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.

http://www.wikidata.org/entity/Q44700024

about

Tumor grade related expression of neuroglobin is negatively regulated by PPARγ and confers antioxidant activity in glioma progression Thermodynamics in Gliomas: Interactions between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma Effect of all-trans retinoic acid on the proliferation and differentiation of brain tumor stem cells.Induction of metastatic gastric cancer by peroxisome proliferator-activated receptorδ activation.Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents.Anaplastic thyroid carcinoma: A comprehensive review of current and future therapeutic options.Amplified inhibition of stellate cell activation pathways by PPAR-γ, RAR and RXR agonists CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid All-trans retinoic acid inhibits migration, invasion and proliferation, and promotes apoptosis in glioma cells in vitro.Anaplastic thyroid carcinoma Treatment resistance mechanisms of malignant glioma tumor stem cells Biological Rationale for the Use of PPARγ Agonists in Glioblastoma Understanding the role of tumor stem cells in glioblastoma multiforme: a review article.PPAR-gamma Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors.A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.All-trans retinoic acid upregulates VEGF expression in glioma cells in vitro.PPARgamma and Agonists against Cancer: Rational Design of Complementation Treatments.Brain fatty acid-binding protein and omega-3/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration.Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors.Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-κB axis.Arsenic, Cadmium, and Lead Like Troglitazone Trigger PPARγ-Dependent Poly (ADP-Ribose) Polymerase Expression and Subsequent Apoptosis in Rat Brain Astrocytes.Therapeutic Potential of Thymoquinone in Glioblastoma Treatment: Targeting Major Gliomagenesis Signaling Pathways.Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas.

P2860

Q33561578-1E7B0B6B-B873-4099-B594-9A7AC84BE56B Q33748280-A14F75C4-F44E-445C-9871-FD25C093DC19 Q34097753-D24C4EFF-39F8-47F2-BB46-A46FF1D116B2 Q34164353-36BCE380-AD2A-4443-AF55-4D9898907FDB Q34618239-A39A012E-310E-4C1B-AAD1-CD2376A8E8D0 Q35000792-EDE72230-5E52-4324-8601-DF2A4AA81482 Q35009520-E343D10E-3C60-44DF-9422-4AAC2B66AF98 Q35742427-0DCD8A48-8C5F-4B0F-901B-498B5937C3B4 Q35759006-B5BB72E6-E659-471C-A32F-0534D875B61B Q36075843-6D2432F1-6722-4CC0-A3B1-3018A03F8D18 Q37129807-8F211266-9605-4055-8DBA-3B0AFA3A8870 Q37636459-78B3C6E1-C746-4C44-9BF7-DCAE78ED5345 Q37790294-D64EC390-4BCB-4258-BFDC-84B8DFCD7717 Q38620031-CF022F28-48F6-4A74-8829-663DC0715D48 Q38885892-7A10CFDB-6991-4D8E-98FC-86917C92F72C Q41158714-9C551813-84FD-4D8B-9B70-1BA67DC8D8A0 Q41677812-38D2E2EC-2182-47C6-BEDF-6E5412659058 Q41984462-FB82EB25-A25F-4F06-93D3-87A6914ADE04 Q42397418-C0808BBB-1239-47E4-AF62-ED8121707651 Q42737831-26654016-930F-4C7B-9328-3E3820E96D2C Q47108426-92DAAB93-94CE-4C8D-A8AD-D91C0AA05222 Q48137852-6B57992C-1222-4337-879A-83781B4CA26D Q52590668-A04F02EC-4371-451A-9BEE-2638009AC154 Q55457391-0CA4B046-8E5E-4F52-95BA-609462BA6112

P2860

Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.

http://www.wikidata.org/entity/Q44700024

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Ligands for PPARgamma and RAR ...... ptosis in human glioblastomas.

@en

Ligands for PPARgamma and RAR ...... ptosis in human glioblastomas.

@nl

type

label

Ligands for PPARgamma and RAR ...... ptosis in human glioblastomas.

@en

Ligands for PPARgamma and RAR ...... ptosis in human glioblastomas.

@nl

prefLabel

Ligands for PPARgamma and RAR ...... ptosis in human glioblastomas.

@en

Ligands for PPARgamma and RAR ...... ptosis in human glioblastomas.

@nl

P1433

Q44700024-06C5C234-B70E-4B0C-863A-0DF22DF44D10

P1476

Q44700024-87EEC414-5C86-4535-B2AF-38478626210A

P2093

Q44700024-1A2CED5A-097F-4F4C-9B10-A2804BE15DB4

Q44700024-2FBE04A3-12A4-481F-9D9D-9A4BFF417774

Q44700024-3FE88082-07D2-49F0-A1CB-CD272C15576E

Q44700024-48C3EFE8-9E5E-46D2-806D-16180959DF46

Q44700024-5412EF88-0128-4E74-9C19-EA3C69E86B1A

Q44700024-86650ED9-AFEE-4C24-BBEE-56274CA0207C

Q44700024-89ADFABF-90FA-4BB8-890F-622E7288E3FB

Q44700024-B8B27CE3-1561-4CB4-A209-6AB661DD0E7F

Q44700024-F11CB1D9-4999-47BC-BCD1-4EEEAD27D9ED

P2888

Q44700024-B4E85CEE-19D7-4839-819A-94D45756F0EE

P304

Q44700024-D1AC76D5-E5EA-456D-9FDC-9BDF412A25D2

P31

Q44700024-604AA895-8034-4C84-992E-3F71FB45D612

P356

Q44700024-D52F123F-5789-46F4-913D-8A6AC07A4A86

P433

Q44700024-9CA423BA-6277-4D21-914D-8204A06E4EE8

P478

Q44700024-51B0A461-E5C6-47BF-9238-090254F308E1

P50

Q44700024-21F0FD12-870D-403B-BB85-0C0E2B74B74E

Q44700024-CAA88D65-22DA-4E13-B620-CC0772F40D0B

P577

Q44700024-CF055817-2654-4E2D-8893-EE3744A1C445

P6179

Q44700024-C2412255-D97A-43E6-8A5E-8C5E39A362EE

P698

Q44700024-44191625-C1F2-47B3-9882-B1A944F0EDFE

P356

B:NEON.0000003728.80052.A8

P1433

Journal of Neuro-Oncology

P1476

Ligands for PPARgamma and RAR ...... ptosis in human glioblastomas.

@en

P2093

Christine Stadelmann

http://www.w3.org/2001/XMLSchema#string

Chuanbing Zang

http://www.w3.org/2001/XMLSchema#string

Elena Elstner

http://www.w3.org/2001/XMLSchema#string

H Phillip Koeffler

http://www.w3.org/2001/XMLSchema#string

Hongyu Liu

http://www.w3.org/2001/XMLSchema#string

Keith L Black

http://www.w3.org/2001/XMLSchema#string

Kurt Possinger

http://www.w3.org/2001/XMLSchema#string

Marlies Wächter

http://www.w3.org/2001/XMLSchema#string

Maximilian G Posch

http://www.w3.org/2001/XMLSchema#string

P2888

b:neon.0000003728.80052.a8

P304

107-118

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1023/B:NEON.0000003728.80052.A8

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Andreas von Deimling

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1044463846

http://www.w3.org/2001/XMLSchema#string

P698

14686729

http://www.w3.org/2001/XMLSchema#string